Literature DB >> 12833521

Human bronchoalveolar lavage: biofluid analysis with special emphasis on sample preparation.

Amelie Plymoth1, Claes-Göran Löfdahl, Ann Ekberg-Jansson, Magnus Dahlbäck, Henrik Lindberg, Thomas E Fehniger, György Marko-Varga.   

Abstract

Respiratory diseases are an important health problem throughout the world. Whether caused by industrial pollutants, infections, smoking, cancer or metabolic diseases, damage to the lungs and airways often lead to morbidity or death. Bronchoalveolar lavage (BAL) obtained by fiber-optic bronchoscopy is a biofluid mirroring the expression of normally secreted pulmonary proteins and the products of activated cells and destructive processes. The characterization of the proteome within this compartment provides an opportunity to establish temporal and prognostic indicators of airway disease. The objective of this study was to develop methods of analysis of BAL samples, which achieved the highest level of annotation of the expression map of this proteome. We have optimized the process of sample preparation after investigating a variety of techniques including dialysis, ultramembrane filtration, precipitation and gel filtration. We have further studied methods to remove albumin from BAL in order to unmask proteins hidden on two-dimensional gels. In a pilot application of the method, BAL protein profiles obtained from healthy nonsmokers and smokers at risk for developing chronic obstructive pulmonary disease showed distinct differences.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12833521     DOI: 10.1002/pmic.200300387

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  12 in total

1.  Exploration of the normal human bronchoalveolar lavage fluid proteome.

Authors:  Jinzhi Chen; Soyoung Ryu; Sina A Gharib; David R Goodlett; Lynn M Schnapp
Journal:  Proteomics Clin Appl       Date:  2008-04       Impact factor: 3.494

Review 2.  Application of glycoproteomics for the discovery of biomarkers in lung cancer.

Authors:  Qing Kay Li; Edward Gabrielson; Hui Zhang
Journal:  Proteomics Clin Appl       Date:  2012-06       Impact factor: 3.494

Review 3.  Shotgun MS proteomic analysis of bronchoalveolar lavage fluid in normal subjects.

Authors:  Elizabeth V Nguyen; Sina A Gharib; Lynn M Schnapp; David R Goodlett
Journal:  Proteomics Clin Appl       Date:  2014-10       Impact factor: 3.494

4.  Identification of differentially expressed proteins in blood plasma of control and cigarette smoke-exposed mice by 2-D DIGE/MS.

Authors:  Arun K Tewari; Alexandra Popova-Butler; Mohamed A El-Mahdy; Jay L Zweier
Journal:  Proteomics       Date:  2011-04-18       Impact factor: 3.984

Review 5.  Human body fluid proteome analysis.

Authors:  Shen Hu; Joseph A Loo; David T Wong
Journal:  Proteomics       Date:  2006-12       Impact factor: 3.984

6.  Proteomic landscape of bronchoalveolar lavage fluid in human immunodeficiency virus infection.

Authors:  Elizabeth V Nguyen; Sina A Gharib; Kristina Crothers; Yu-Hua Chow; David R Park; David R Goodlett; Lynn M Schnapp
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-11-08       Impact factor: 5.464

7.  Proteomic analysis of human bronchoalveolar lavage fluid after subsgemental exposure.

Authors:  Matthew W Foster; J Will Thompson; Loretta G Que; Ivana V Yang; David A Schwartz; M Arthur Moseley; Harvey E Marshall
Journal:  J Proteome Res       Date:  2013-04-24       Impact factor: 4.466

Review 8.  Glycoproteomics using fluid-based specimens in the discovery of lung cancer protein biomarkers: promise and challenge.

Authors:  Qing Kay Li; Ed Gabrielson; Frederic Askin; Daniel W Chan; Hui Zhang
Journal:  Proteomics Clin Appl       Date:  2013-01       Impact factor: 3.494

9.  Large-scale, ion-current-based proteomics investigation of bronchoalveolar lavage fluid in chronic obstructive pulmonary disease patients.

Authors:  Chengjian Tu; Manoj Jacob Mammen; Jun Li; Xiaomeng Shen; Xiaosheng Jiang; Qiang Hu; Jianmin Wang; Sanjay Sethi; Jun Qu
Journal:  J Proteome Res       Date:  2013-12-02       Impact factor: 4.466

10.  Outcome prediction in pneumonia induced ALI/ARDS by clinical features and peptide patterns of BALF determined by mass spectrometry.

Authors:  Jochen Frenzel; Christian Gessner; Torsten Sandvoss; Stefan Hammerschmidt; Wolfgang Schellenberger; Ulrich Sack; Klaus Eschrich; Hubert Wirtz
Journal:  PLoS One       Date:  2011-10-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.